The COVID-19 pandemic caused by the SARS-CoV-2 virus made it necessary to search for
new options for both causal treatment and mitigation of its symptoms. Scientists and …

The lungs, in addition to participating in gas exchange, represent the first line of defense
against inhaled pathogens and respiratory toxicants. Cells lining the airways and alveoli …

Cannabinoids, mainly cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC), are the most
studied group of compounds obtained from Cannabis sativa because of their several …

During the COVID-19 pandemic lasting now for well more than a year, nearly 247 million
cases have been diagnosed and over 5 million deaths have been recorded worldwide as of …

Antibiotic resistance has become an increasing challenge in the treatment of various
infectious diseases, especially those associated with biofilm formation on biotic and abiotic …

In late 2019, COVID-19 emerged in Wuhan, China. Currently, it is an ongoing global health
threat stressing the need for therapeutic compounds. Linking the virus life cycle and its …

Cytokine storm refers to the dysregulated production of inflammatory mediators leading to
hyperinflammation. They are often detrimental, and worsen the severity of COVID-19 and …

Antimicrobial resistance has emerged as a global health crisis and, therefore, new drug
discovery is a paramount need. Cannabis sativa contains hundreds of chemical constituents …

Coronaviruses are a large family of viruses that cause illnesses ranging from the common
cold to more severe diseases such as Middle East Respiratory Syndrome (MERS), Severe …

Background Tranilast is a potential NLRP3 inflammasome inhibitor that may relieve
progressive inflammation due to COVID-19. Aim of the study To evaluate the therapeutic …